rxstatShortages › Tamsulosin

Tamsulosin shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Tamsulosin products are in shortage in Canada (4 of 10 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Nov 13, 2026.
Products affected
4 / 10
In shortage since
Nov 18, 2024
Est. full return
Nov 13, 2026
Reports on file
72
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
SANDOZ TAMSULOSIN CR
0.4MG · TABLET (EXTENDED-RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02340208 · since Jun 22, 2026, est. end Sep 4, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP TAMSULOSIN
0.4MG · CAPSULE (SUSTAINED-RELEASE) · JAMP PHARMA CORPORATION
DIN 02352419 · since Feb 20, 2026, est. end Nov 13, 2026 · Disruption of the manufacture of the drug.
Active shortage
TEVA-TAMSULOSIN CR
0.4MG · TABLET (EXTENDED-RELEASE) · TEVA CANADA LIMITED
DIN 02368242 · since Jun 10, 2026, est. end Jul 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
TAMSULOSIN CR
0.4MG · TABLET (EXTENDED-RELEASE) · SANIS HEALTH INC
DIN 02427117 · since Nov 18, 2024, no end estimate · Disruption of the manufacture of the drug.
Resolved
SANDOZ TAMSULOSIN CR
0.4MG · TABLET (EXTENDED-RELEASE) · SANDOZ CANADA INCORPORATED
DIN 02340208 · ended Jun 30, 2025 · Demand increase for the drug.
Resolved
TEVA-TAMSULOSIN CR
0.4MG · TABLET (EXTENDED-RELEASE) · TEVA CANADA LIMITED
DIN 02368242 · ended Nov 10, 2024 · Disruption of the manufacture of the drug.
Discontinued
FLOMAX CR
0.4MG · TABLET (EXTENDED-RELEASE) · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02270102
Resolved
TEVA-TAMSULOSIN CR
0.4MG · TABLET (EXTENDED-RELEASE) · TEVA CANADA LIMITED
DIN 02368242 · ended Oct 1, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-TAMSULOSIN CR
0.4MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02362406 · ended Nov 14, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-TAMSULOSIN CR
0.4MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02362406 · ended Nov 14, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-TAMSULOSIN CR
0.4MG · TABLET (EXTENDED-RELEASE) · APOTEX INC
DIN 02362406 · ended Nov 14, 2024 · Shortage of an active ingredient.
Resolved
TAMSULOSIN CR
0.4MG · TABLET (EXTENDED-RELEASE) · SANIS HEALTH INC
DIN 02427117 · ended Jul 4, 2024 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Tamsulosin is currently affected by 4 active shortage reports filed with Health Canada by SANDOZ CANADA INCORPORATED, JAMP PHARMA CORPORATION, TEVA CANADA LIMITED, SANIS HEALTH INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Tamsulosin is classified under “DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY” (ATC G04CA).

Recent changes

Common questions

When will Tamsulosin be back in stock in Canada?

The latest manufacturer estimate is Nov 13, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Tamsulosin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (drugs used in benign prostatic hypertrophy)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.